Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in decreased expression of FBN2 mRNA | decreases expression | 20406850
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of FBN2 protein | affects expression | 20106945
|
C459604 |
candoxin |
candoxin results in decreased expression of FBN2 mRNA | decreases expression | 16309724
|
D003345 |
Corticosterone |
Corticosterone results in increased expression of FBN2 mRNA | increases expression | 15755911
|
D003907 |
Dexamethasone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FBN2 mRNA | affects cotreatment|decreases expression | 16054899
|
D003907 |
Dexamethasone |
Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FBN2 mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of FBN2 mRNA | decreases expression | 15834898 17557909
|
D015056 |
1-Methyl-3-isobutylxanthine |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FBN2 mRNA | affects cotreatment|decreases expression | 16054899
|
D015056 |
1-Methyl-3-isobutylxanthine |
Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FBN2 mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899
|
C011890 |
kojic acid |
kojic acid results in increased expression of FBN2 mRNA | increases expression | 16595896
|
C076994 |
perfluorooctane sulfonic acid |
perfluorooctane sulfonic acid results in decreased expression of FBN2 mRNA | decreases expression | 17560707
|
C025299 |
polyphenols |
polyphenols results in decreased expression of FBN2 mRNA | decreases expression | 16293270
|
C089730 |
rosiglitazone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FBN2 mRNA | affects cotreatment|decreases expression | 16054899
|
C089730 |
rosiglitazone |
Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FBN2 mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FBN2 mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.00 | 11752688 15322242 14514962 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.12 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.83 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.53 | 16835633 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
2.87 | 19621015 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.05 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.60 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
7.59 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.59 | 15885639 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.15 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.83 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.70 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.08 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
3.08 | 12619106 21507988 12907637 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.42 | 16120746 18850075 18670907 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
2.84 | 6135515 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.26 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.95 | 16105132 17681005 17333356 16919318 15861022 11677210 17110522 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.14 | 8697196 12621046 15340226 16354765 15668235 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
4.15 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
4.15 | 16293270 |
MESH:D015179 |
Colorectal Neoplasms |
marker/mechanism |
|
| 21278247 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 14669216 17141729 |
OMIM:121050 |
CONTRACTURAL ARACHNODACTYLY, CONGENITAL |
marker/mechanism |
|
| |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
2.64 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.64 | 10048152 15322242 20055451 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.16 | 18551238 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
3.54 | 12438553 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
4.40 | 17446233 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
4.58 | 12642470 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.58 | 17107852 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.82 | 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.44 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
6.44 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.44 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.84 | 11462148 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
4.59 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
12.24 | 19703484 |
MESH:D004487 |
Edema |
|
rosiglitazone |
12.24 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
12.24 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.08 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.31 | 12538720 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.12 | 10568697 9294722 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.09 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
8.34 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
8.34 | 19196556 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.59 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.09 | 20067830 |
MESH:D005909 |
Glioblastoma |
|
perfluorooctane sulfonic acid |
4.33 | 17162496 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.77 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.38 | 10048152 11294989 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.44 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.03 | 15340226 16120746 12621046 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
3.10 | 7520565 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.22 | 16959395 15340226 18606429 8697196 16354765 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
4.00 | 12083418 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
5.38 | 17042910 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.38 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.95 | 16569931 16945680 |
MESH:D007077 |
Ileal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.62 | 18306037 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.58 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.56 | 17937319 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
12.50 | 11099482 8960868 |
MESH:D007249 |
Inflammation |
|
polyphenols |
12.50 | 16366677 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
12.50 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
12.50 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
3.87 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.44 | 16580747 |
MESH:D007579 |
Jejunal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.62 | 18306037 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.07 | 16705839 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
3.68 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
3.68 | 17347453 15980055 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.68 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
2.80 | 16698588 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
7.62 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
7.62 | 9163691 15890375 18177683 2125692 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.62 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
14.70 | 6135515 2876786 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
14.70 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
kojic acid |
14.70 | 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
14.70 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
3.52 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
3.52 | 11195469 15824018 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.52 | 11884234 19555203 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Corticosterone |
6.87 | 12807724 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
6.87 | 16827153 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
4.47 | 17261469 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
3.58 | 15867202 16118317 15744524 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
3.60 | 9809623 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.11 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.01 | 7678174 18551238 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.34 | 14600291 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.53 | 16049721 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.80 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.42 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.69 | 18163543 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.60 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.34 | 11399792 11118676 11222880 11896295 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.47 | 16919318 15861022 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
4.13 | 18379247 11700416 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 18990726 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.61 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.09 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.12 | 16709447 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
4.47 | 15472012 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
3.59 | 15138204 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
5.43 | 17997062 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.74 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.25 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.08 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.33 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.47 | 10091137 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.42 | 14692618 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
4.99 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.77 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.65 | 15869587 14671159 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.42 | 15886252 |